EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 6th, 2013 • Cornerstone Therapeutics Inc • Pharmaceutical preparations • North Carolina
Contract Type FiledAugust 6th, 2013 Company Industry JurisdictionThis EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of the Effective Date set out in paragraph 1, by and between Cornerstone Therapeutics Inc., a Delaware corporation (the “Company”), and Andreas Maetzel, M.D., M.Sc., Ph.D.,. (the “Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • September 6th, 2011 • Cornerstone Therapeutics Inc • Pharmaceutical preparations • North Carolina
Contract Type FiledSeptember 6th, 2011 Company Industry JurisdictionThis EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of September 6, 2011 (the “Effective Date”), by and between Cornerstone Therapeutics Inc., a Delaware corporation (the “Company”), and Kenneth R. McBean (the “Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 7th, 2011 • Cornerstone Therapeutics Inc • Pharmaceutical preparations • North Carolina
Contract Type FiledFebruary 7th, 2011 Company Industry JurisdictionThis EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of February 1, 2011 (the “Effective Date”), by and between Cornerstone Therapeutics Inc., a Delaware corporation (the “Company”), and Vincent T. Morgus (the “Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • March 4th, 2010 • Cornerstone Therapeutics Inc • Pharmaceutical preparations • North Carolina
Contract Type FiledMarch 4th, 2010 Company Industry JurisdictionThis EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of October 30, 2009, 2009 (the “Effective Date”), by and between Cornerstone Therapeutics Inc., a Delaware corporation (the “Company”), and Andrew K. W. Powell (the “Executive”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 12th, 2009 • Cornerstone Therapeutics Inc • Pharmaceutical preparations • North Carolina
Contract Type FiledMay 12th, 2009 Company Industry JurisdictionThis EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of May 6, 2009, by and between Cornerstone Therapeutics Inc., a Delaware corporation (the “Company”), and Alan Roberts (the “Executive”). This Agreement shall be effective on the Closing Date (as such term is defined in the Stock Purchase Agreement, dated the same date as this Agreement between the Company and Chiesi Farmaceutici SpA (the “Effective Date”).
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 12th, 2009 • Cornerstone Therapeutics Inc • Pharmaceutical preparations • North Carolina
Contract Type FiledMay 12th, 2009 Company Industry JurisdictionThis AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of May 6, 2009, by and between Cornerstone Therapeutics Inc., a Delaware corporation (the “Company”), and Brian Dickson, M.D. (the “Executive”). This Agreement shall be effective on the Closing Date (as such term is defined in the Stock Purchase Agreement, dated the same date as this Agreement between the Company and Chiesi Farmaceutici SpA (the “Effective Date”).
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 12th, 2009 • Cornerstone Therapeutics Inc • Pharmaceutical preparations • North Carolina
Contract Type FiledMay 12th, 2009 Company Industry JurisdictionThis AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of May 6, 2009, by and between Cornerstone Therapeutics Inc., a Delaware corporation (the “Company”), and Joshua Franklin (the “Executive”). This Agreement shall be effective on the Closing Date (as such term is defined in the Stock Purchase Agreement, dated the same date as this Agreement between the Company and Chiesi Farmaceutici SpA (the “Effective Date”).
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 12th, 2009 • Cornerstone Therapeutics Inc • Pharmaceutical preparations • North Carolina
Contract Type FiledMay 12th, 2009 Company Industry JurisdictionThis AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of May 6, 2009, by and between Cornerstone Therapeutics Inc., a Delaware corporation (the “Company”), and Steven M. Lutz (the “Executive”). This Agreement shall be effective on the Closing Date (as such term is defined in the Stock Purchase Agreement, dated the same date as this Agreement, between the Company and Chiesi Farmaceutici SpA (the “Effective Date”).
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 12th, 2009 • Cornerstone Therapeutics Inc • Pharmaceutical preparations • North Carolina
Contract Type FiledMay 12th, 2009 Company Industry JurisdictionThis AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of May 6, 2009 by and between Cornerstone Therapeutics Inc., a Delaware corporation (the “Company”), and Craig A. Collard (the “Executive”). This Agreement shall be effective on the Closing Date (as such term is defined in the Stock Purchase Agreement, dated the same date as this Agreement, between the Company and Chiesi Farmaceutici SpA (the “Effective Date”).
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 12th, 2009 • Cornerstone Therapeutics Inc • Pharmaceutical preparations • North Carolina
Contract Type FiledMay 12th, 2009 Company Industry JurisdictionThis AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of May 6, 2009, by and between Cornerstone Therapeutics Inc., a Delaware corporation (the “Company”), and David Price (the “Executive”). This Agreement shall be effective on the Closing Date (as such term is defined in the Stock Purchase Agreement, dated the same date as this Agreement between the Company and Chiesi Farmaceutici SpA (the “Effective Date”).